Abstract
According to the expansion of lifespan, neuronal disorder based on inflammation has been social problem. Therefore, we isolated shikonin from Lithospermum erythrorhizon and evaluated anti-inflammatory effects of shikonin in lipopolysaccharide (LSP)-stimulated BV2 microglial cells. Shikonin dose-dependently inhibits the expression of the proinflammatory mediators, nitric oxide (NO), prostaglandin E2 (PGE2), and tumor necrosis factor-α (TNF-α) as well as their main regulatory genes and products such as inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), and TNF-α in LPS-stimulated BV2 microglial cells. Additionally, shikonin suppressed the LPS-induced DNA-binding activity of nuclear factor-κB (NF-κB) to regulate the key regulatory genes of the proinflammatory mediators, such as iNOS, COX-2, and TNF-α, accompanied with downregulation of reactive oxygen species (ROS) generation. The results indicate that shikonin may downregulate the expression of proinflammatory genes involved in the synthesis of NO, PGE2, and TNF-α in LPS-treated BV2 microglial cells by suppressing ROS and NF-κB. Taken together, our results revealed that shikonin exerts downregulation of proinflammatory mediators by interference the ROS and NF-κB signaling pa...Continue Reading
References
Sep 23, 1994·Cell·C Nathan, Q W Xie
Jan 1, 1994·Annual Review of Medicine·K J Tracey, A Cerami
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Feb 18, 1999·Molecular and Cellular Biology·G BonizziV Bours
Apr 15, 1999·Annual Review of Neuroscience·F González-Scarano, G Baltuch
Jul 2, 1999·The American Journal of Medicine·P E Lipsky
Aug 2, 2001·The Journal of Biological Chemistry·S H KornY M Janssen-Heininger
Aug 17, 2001·Mutation Research·Y J SurhS S Lee
Dec 7, 2002·Hypertension·Klaus HöcherlMichael Bucher
Feb 28, 2003·Molecular Pharmacology·Yang Hee ChoSang Geon Kim
May 15, 2003·British Journal of Pharmacology·Ae Kyung LeeSang Geon Kim
Dec 3, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Baolu Zhao
Aug 6, 2005·Progress in Neurobiology·Michelle L Block, Jau-Shyong Hong
Sep 24, 2005·Nucleic Acids Research·Sybille KempeThomas Wirth
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Jan 18, 2007·Expert Opinion on Therapeutic Targets·Simonetta Camandola, Mark P Mattson
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Akira Murakami, Hajime Ohigashi
Aug 12, 2008·Current Medicinal Chemistry·P J CiminoThomas J Montine
Nov 26, 2008·Cancer Letters·Yanyan Xuan, Xun Hu
Aug 26, 2010·British Journal of Pharmacology·Chen-Chen LeeYu-Wen Cheng
Nov 26, 2010·Immunotherapy·Léia C R SilvaGil Benard
Nov 24, 2011·Neuroscience Bulletin·Gayle Helane Doherty
Jan 14, 2012·Journal of Neuroinflammation·Liya Qin, Fulton T Crews
Jan 10, 2013·PloS One·Hao WuXun Hu
Apr 23, 2013·Journal of Neuroimmunology·Sun-Uk KimDong-Seok Lee
May 9, 2013·International Immunopharmacology·Dejie LiangYongguo Cao
Jun 4, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·I AndújarM C Recio
Oct 15, 2013·Molecular Neurodegeneration·Ayesha MaqboolBernd Baumann
Nov 5, 2013·Biochemical and Biophysical Research Communications·Noriaki KawanishiKatsuhiko Suzuki
Nov 20, 2013·Neurochemical Research·Lina WangHuimin Qiao
Dec 5, 2013·PloS One·Feng-Lei ZhangYi-Xue Xue
Jan 23, 2014·International Immunopharmacology·Ying YangZhi Chen
Mar 29, 2014·Apoptosis : an International Journal on Programmed Cell Death·Kyriaki ZikakiIsidoros Beis
Apr 10, 2014·PloS One·Jen-Tsung YangChing-Hsein Chen
Jun 26, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wan-Rong HuangXin Tang